News
Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of ...
Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.
Free Malaysia Today on MSN15h
Pfizer’s earnings boosted by Covid-19 products, lower expensesPfizer was among the 17 companies that received a July 31 letter from president Donald Trump demanding lower drug prices.
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...
MedPage Today on MSN1d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season?The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
Pfizer (NYSE:PFE) stock gains as the company surpasses Q2 2025 expectations with $14.7B revenue and raises its full-year ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback